Will These 5 Medical Device Stocks Beat This Earnings Season?

Yahoo FinanceMay 6 23:12

Nevro Corp Announces Chief Accounting Officer Resignation

TipRanksApr 26 05:22

Nevro to Report First-Quarter 2024 Financial Results and Host Earnings Conference Call on May 7, 2024

Nevro Corp. (NYSE: NVRO), a global medical device company delivering comprehensive, life-changing solutions for the treatment of chronic pain, today...

PR NewswireApr 17 20:30

RBC Capital Sticks to Their Hold Rating for Nevro Corp (NVRO)

TipRanksApr 17 15:59

Nevro Is Maintained at Sector Perform by RBC Capital

Nevro Is Maintained at Sector Perform by RBC Capital

Dow JonesApr 16 02:31

RBC Capital Maintains Sector Perform on Nevro, Lowers Price Target to $16

RBC Capital analyst Shagun Singh maintains Nevro with a Sector Perform and lowers the price target from $18 to $16.

Analyst UpgradesApr 16 02:21